remyelination with opicinumab (anti-lingo-1) for multiple sclerosis [phase ii trial results]
Published 3 years ago • 4.2K plays • Length 13:12Download video MP4
Download video MP3
Similar videos
-
10:57
masitinib for multiple sclerosis-phase iib/iii trial results
-
23:53
use of anti-lingo 1 for remyelination in tm and nmo
-
10:46
remyelination for multiple sclerosis [clemastine]
-
7:04
tysabri vs. gilenya for multiple sclerosis [reveal trial results]
-
1:43
ms research using vision (oct) testing: anti-lingo-1
-
12:50
multiple sclerosis terminology (exacerbation, progression, t1, t2, uhtoff's, lhermitte's, and more)
-
18:05
temelimab for multiple sclerosis explained by neurologist
-
13:20
how to find a multiple sclerosis clinical trial [neurologist explains]
-
10:36
is ms actually autoimmune?
-
17:42
do multiple sclerosis meds work long-term? [response to living proof documentary by matt embry]
-
10:52
resilience in multiple sclerosis
-
40:21
remyelination in real time in a living mouse! 2020 barancik prize winner prof dwight bergles ph.d.
-
58:42
“remyelination in multiple sclerosis” by dr. jenny feng
-
12:26
neurologist summarizes wahls protocol for multiple sclerosis
-
1:20
understanding inflammation and progression in multiple sclerosis
-
7:16
diet halves ms relapses! [ausimmune study results]
-
7:08
is multiple sclerosis genetic (% risk in relatives)
-
2:53
multiple sclerosis remyelination trial update: metformin and clemastine
-
7:27
multiple sclerosis